[The therapeutic effect of L-dopa].
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001249:Asthma / Q000188:drug therapy; D001921:Brain / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000096:biosynthesis / Q000494:pharmacology / Q000627:therapeutic use*; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D007022:Hypotension / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D009127:Muscle Rigidity / Q000188:drug therapy; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine
Die therapeutische Wirkung von L-DOP.